Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
While GLP-1 receptor agonists, like semaglutide (found in medications such as Wegovy and Ozempic), are associated with weight loss, individual responses can vary greatly
Emerging Data on Nerve and Stem Cell Research Some studies imply that GHK-Cu may encourage nerve growth processes through interactions with growth factor expression
In separate trials, tirzepatide 15 mg produced 20.9% average weight loss compared to semaglutide 2.4 mg at 14.9%
